HOUSE AMENDMENT |
Bill No. HB 1E CS |
|
|
|
|
1
|
CHAMBER ACTION |
2
|
|
3
|
. |
4
|
. |
5
|
. |
6
|
|
7
|
|
8
|
|
9
|
|
10
|
|
11
|
|
12
|
Representative Sobel offered the following: |
13
|
|
14
|
Amendment to Amendment (565379) |
15
|
Remove line(s) 463-509, and insert: |
16
|
(a) The grantee shall reinvest 15 percent of the net |
17
|
royalty revenues and of the revenues from the sale of stock |
18
|
received by The Scripps Research Institute from the licensing or |
19
|
transfer of inventions, methods, processes, and other patentable |
20
|
activities conceived or reduced to practice using facilities or |
21
|
employees of the grantee. For purposes of this paragraph, the |
22
|
term “net royalty revenues” means all royalty revenues less the |
23
|
cost of obtaining, maintaining, and enforcing related patent and |
24
|
intellectual property rights, both foreign and domestic. |
25
|
Reinvestment payments under this subsection shall commence no |
26
|
later than 6 months after the grantee has received the final |
27
|
disbursement under the contract.
|
28
|
(b) The grantee shall reinvest 15 percent of the gross |
29
|
revenues it receives from naming opportunities associated with |
30
|
any facility it builds in this state. For purposes of this |
31
|
paragraph, the term “naming opportunities” includes charitable |
32
|
donations from any person in consideration for the right to have |
33
|
all or a portion of the facility named for or in the memory of |
34
|
any person, living or dead, or for any entity. The obligation to |
35
|
make reinvestment payments under this subsection shall commence |
36
|
upon the execution of the contract between the corporation and |
37
|
the grantee.
|
38
|
|
39
|
All public universities and private not-for-profit universities |
40
|
in this state shall receive 75 percent of reinvestment payments |
41
|
made pursuant to this subsection and 25 percent of such payments |
42
|
shall be remitted to the state for deposit in the Biomedical |
43
|
Research Trust Fund, or if such fund has ceased to exist, in |
44
|
another trust fund that supports biomedical research, as |
45
|
determined by law. |